FUNI (Hypha Labs) 3-1 Month Momentum %: -47.37% (As of Jul. 19, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Hypha Labs 3-1 Month Momentum %?

Hypha Labs FUNI +0.54% 3-1 Month Momentum % is -47.37% as of Jul. 19, 2026. The stock has 2 warning signs investors should review. Among 215 Medical Diagnostics & Research companies, Hypha Labs ranks worse than 93.49% on this metric.

3-1 Month Momentum % is the total return of the stock from 3-month ago to 1-month ago. As of today (2026-07-19), Hypha Labs's 3-1 Month Momentum % is -47.37%.

The industry rank for Hypha Labs's 3-1 Month Momentum % or its related term are showing as below:

FUNI's 3-1 Month Momentum % is ranked worse than
93.49% of 215 companies
in the Medical Diagnostics & Research industry
Industry Median: -8.05 vs FUNI: -47.37

Hypha Labs  (OTCPK:FUNI) 3-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 3-1 Month Momentum % measures the total return to a stock over the past three months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.

Hypha Labs 3-1 Month Momentum % Related Terms

FUNI vs IVRO, PRPH, IDTA: 3-1 Month Momentum % Comparison

For the Diagnostics & Research subindustry, Hypha Labs's 3-1 Month Momentum %, along with its competitors' market caps and 3-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hypha Labs 3-1 Month Momentum % vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Hypha Labs's 3-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Hypha Labs's 3-1 Month Momentum % falls into.


Hypha Labs  (OTCPK:FUNI) 3-1 Month Momentum % Calculation

3-1 Month Momentum % is calculated as following:

3-1 Month Momentum %=( Price 1-month ago / Price 3-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about 3-1 Month Momentum % →
What does a 3-1 Month Momentum % of -47.37% mean?
Hypha Labs (FUNI) has a 3-1 Month Momentum % of -47.37% as of Jul. 19, 2026. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Hypha Labs and its competitors. According to the industry distribution chart, Hypha Labs ranks #201 out of 215 companies in the Medical Diagnostics & Research industry, placing it in the top 93.5%.
Is Hypha Labs' 3-1 Month Momentum % too high?
Hypha Labs' current 3-1 Month Momentum % is -47.37%. Based on the distribution chart, Hypha Labs ranks #201 out of 215 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers.
How does Hypha Labs' 3-1 Month Momentum % compare to IVRO and PRPH?
According to the Medical Diagnostics & Research industry distribution chart, Hypha Labs ranks #201 out of 215 companies for 3-1 Month Momentum %. This places Hypha Labs in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-1 Month Momentum % for a Medical Diagnostics & Research company?
A good 3-1 Month Momentum % depends on the Medical Diagnostics & Research industry context. However, 3-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-1 Month Momentum % mean?
A high 3-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Hypha Labs and its competitors. Hypha Labs's current 3-1 Month Momentum % is -47.37%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hypha Labs stock overvalued right now?
Hypha Labs (FUNI) has a current 3-1 Month Momentum % of -47.37%. The current 3-1 Month Momentum % is -47.37%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-1 Month Momentum % calculated?
3-1 Month Momentum % is calculated from a company's financial statements. For Hypha Labs (FUNI), the current 3-1 Month Momentum % is -47.37% as of Jul. 19, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Hypha Labs Business Description

Address 5940 S. Rainbow Boulevard, Las Vegas, NV, USA, 89118
Hypha Labs Inc engaged in the research, development, and commercialization of the Hypha Micropearl accelerator, an in-home, web-based, computer-controlled bioreactor designed to accelerate the production of nutritionally beneficial mushrooms for human consumption. The Company's easy-to-use device, together with replaceable cartridges ordered through its exclusive app, safely and effectively produced enriched mycelium of functional mushrooms, or Micropearls, in eight days. These Micropearls contained active mushroom ingredients in a concentrated, easy-to-handle, tasteless, and odorless form that could be incorporated into various foods and beverages without altering flavor.